Limbal stem cells are responsible for the continuous renewal of the corneal epithelium. The
destruction or dysfunction of these stem cells or their niche induces limbal stem cell …

Background and Aims The molecular mechanisms driving non‐alcoholic fatty liver disease (NAFLD)
are poorly understood; however, microRNAs might play a key role in these …

Background & Aims Molecular mechanisms by which hypoxia might contribute to hepatosteatosis,
the earliest stage in non‐alcoholic fatty liver disease (NAFLD) pathogenesis, remain …

Hepatic vitamin D receptor (VDR) expression is increased in patients with nonalcoholic fatty
liver (NAFL) and is required for liver steatosis in an NAFL mouse model. However, how …

Background: Since the confirmation of the first patient infected with SARS-CoV-2 in Spain in
January 2020, the epidemic has grown rapidly, with the greatest impact on the region of …

Objectives Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
in Western countries. Protein tyrosine phosphatase 1B (PTP1B), a negative modulator of …

The transplantation of limbal epithelial stem cells (LESCs) cultured in vitro is a great advance
in the treatment of patients suffering from LESC deficiency. However, the optimal technique …

Background Proton pump inhibitors (PPIs) are the most commonly used first‐line therapy for
patients with eosinophilic oesophagitis (EoE). However, many aspects related to PPIs in …

Insulin receptor substrate 2 (IRS2) is a key downstream mediator of insulin and insulin-like
growth factor 1 (IGF1) signalling pathways and plays a major role in liver metabolism. The …

Nocturnal intermittent hypoxia (IH) featuring obstructive sleep apnea (OSA) dysregulates
hepatic lipid metabolism and might contribute to the development of non-alcoholic fatty liver …